Jonathan Kaplan, DPM
Podiatrist · Wellesley, MANPI 1053491696
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $51,080 of the $55,857 with a category attached, or 91.4%. 11 manufacturers reported payments, led by Vilex LLC at 49.8% of the total. Among podiatrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 44 payments — averaging $1269.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vilex LLC$28K
- Treace Medical Concepts, Inc.$27K
- Amgen$237
- Medshape, Inc.$150
- Stryker$142
- Orthofix Medical, Inc.$87
- plus $166 from 5 others
What the payments were for
- Consulting fees$51,08091%
- Travel & lodging$3,8707%
- Food & beverage$9072%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vilex LLC | 1 | $27,830 |
| Treace Medical Concepts, Inc. | 26 | $27,246 |
| Amgen | 2 | $237 |
| Medshape, Inc. | 1 | $150 |
| Stryker | 3 | $142 |
| Orthofix Medical, Inc. | 3 | $87 |
| Smith+Nephew | 3 | $80 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Nevro Corp. | 1 | $24 |
| Melinta Therapeutics, LLC | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HINTERMANN$27,830
- LAPIPLASTY SYSTEM 1$26,231
- Lapiplasty System$709
- KRYSTEXXA$237
- DynaNail$150
How this compares
$55,857 in reported general payments places this provider in the 95th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 24 | $663 |
| Terbinafine Hcl | 15 | $232 |
| Cephalexin | 33 | $196 |
| Econazole Nitrate | 11 | $164 |
| Mupirocin | 16 | $148 |
| Methylprednisolone | 19 | $100 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Wellesley
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
- Louis DecaroWest Hatfield$19K
- Daren BergmanFramingham$15K
- Carl ConuiReading$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.